Evidence map›Paper›PMID 21068834›Full record

ReviewNature2010

The myeloid cells of the central nervous system parenchyma.

Richard M Ransohoff, Astrid E Cardona

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 432 papers.

0numbers the graph read from it
0cells of the map it votes in
432citing papers in PubMed
41.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

432 citing papers in PubMed, 783 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

372 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Richard M RansohoffNeuroinflammation Research Center (Department of Neurosciences, Lerner Research Institute) and Mellen Center for MS Treatment and Research (Neurological Institute), Cleveland Clinic, Mail Code NC30, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA. ransohr@ccf.org
Astrid E Cardona
Cleveland Clinic Lerner College of Medicine · USTexas Center for Infectious Disease · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A microglial cell is both a glial cell of the central nervous system and a mononuclear phagocyte, which belongs to the haematopoietic system and is involved in inflammatory and immune responses. As such, microglia face a challenging task. The neurons of the central nervous system cannot divide and be replenished, and therefore need to be protected against pathogens, which is a key role of the immune system, but without collateral damage. In addition, after physical injury, neural cells need restorative support, which is provided by inflammatory responses. Excessive or chronic inflammatory responses can, however, be harmful. How microglia balance these demands, and how their behaviour can be modified to ameliorate disorders of the central nervous system, is becoming clear.

Indexed as

AnimalsCell LineageCentral Nervous SystemHumansMicrogliaMyeloid CellsPhagocytesStem Cells

Identifiers

PMID21068834
OpenAlexW2004492484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.